Antibiotics accumulate in <i>Klebsiella pneumoniae</i> liver abscesses but fail to eliminate antibiotic-tolerant populations

M Michelle Angeles-Solano (Department of Microbiology and Immunology, University of North Carolina) Z Zajeba Tabashsum (Department of Microbiology and Immunology, University of North Carolina) J Jamie D. Liu (Department of Microbiology and Immunology, University of North Carolina) Z Zachary J. Lifschin (Department of Microbiology and Immunology, University of North Carolina) N Nikki J. Wagner (Department of Microbiology and Immunology, University of North Carolina) K Kaleb J. Tyson (Department of Microbiology and Immunology, University of North Carolina) L Liang Chen R Rani S. Sellers (Department of Pathology and Laboratory Medicine, University of North Carolina) K Kimberly A. Walker (Department of Microbiology and Immunology, University of North Carolina) Y Yury Desyaterik (Eshelman School of Pharmacy, University of North Carolina) E Elias P. Rosen (Eshelman School of Pharmacy, University of North Carolina) S Sarah E. Rowe (Department of Microbiology and Immunology, University of North Carolina)

Abstract

Liver abscesses caused by hypervirulent Klebsiella pneumoniae (hvKp) can lead to severe metastatic complications, with mortality rates ranging from 5 to 40%. Even in the absence of antibiotic resistance, hvKp liver abscesses often respond poorly to treatment, sometimes requiring surgical resection. The reason for these poor outcomes remains unknown. Here, we established an hvKp wound model in outbred immunocompetent mice, which progresses to systemic infection and hepatic abscesses that were intractable to antibiotic therapy. Using a combination of quantitative and infrared matrix-assisted laser desorption electrospray ionization imaging mass spectrometry, we found that antibiotics fail to kill K. pneumoniae in liver abscesses, independently of resistance or spatial distribution of antibiotics. Our results show that antibiotic concentrations detected in the liver are sufficient to eradicate hvKp under standard in vitro conditions, but the continued presence of viable bacteria in vivo indicates that hvKp adopts an antibiotic-tolerant state within the liver. Notably, the inadequate antibiotic efficacy observed in our mouse studies mirrors clinical outcomes. These findings underscore the urgent need to elucidate the mechanism underlying hvKp tolerance, which could inform the development of novel therapeutic approaches.

Article Details

Volume / Issue Vol. 122, Issue 48
Published December 02, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (12)

M

Michelle Angeles-Solano

Department of Microbiology and Immunology, University of North Carolina

Z

Zajeba Tabashsum

Department of Microbiology and Immunology, University of North Carolina

J

Jamie D. Liu

Department of Microbiology and Immunology, University of North Carolina

Z

Zachary J. Lifschin

Department of Microbiology and Immunology, University of North Carolina

N

Nikki J. Wagner

Department of Microbiology and Immunology, University of North Carolina

K

Kaleb J. Tyson

Department of Microbiology and Immunology, University of North Carolina

L

Liang Chen

R

Rani S. Sellers

Department of Pathology and Laboratory Medicine, University of North Carolina

K

Kimberly A. Walker

Department of Microbiology and Immunology, University of North Carolina

Y

Yury Desyaterik

Eshelman School of Pharmacy, University of North Carolina

E

Elias P. Rosen

Eshelman School of Pharmacy, University of North Carolina

S

Sarah E. Rowe

Department of Microbiology and Immunology, University of North Carolina